Does thromboprophylaxis reduce the risk of acute cerebrovascular events (ACV)?

Thromboprophylaxis, including DOACs and antiplatelet agents, significantly reduces the risk of acute cerebrovascular events, though risks like bleeding warrant careful patient monitoring and selection.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-09
DOI
https://doi.org/10.5281/zenodo.24083367
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Does thromboprophylaxis reduce the risk of acute cerebrovascular events (ACV)?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Acute Ischemic Stroke Management
article

Does thromboprophylaxis reduce the risk of acute cerebrovascular events (ACV)?

Tripdatabase
article en

Abstract

Thromboprophylaxis, including DOACs and antiplatelet agents, significantly reduces the risk of acute cerebrovascular events, though risks like bleeding warrant careful patient monitoring and selection.

Zenodo (CERN European Organization for Nuclear Research)
Acute Ischemic Stroke Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Does thromboprophylaxis reduce the risk of acute cerebrovascular events (ACV)? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS